Avadel Stock Future Price Prediction

AVDL -  USA Stock  

USD 8.14  0.38  4.46%

Avadel Pharmaceuticals stock price prediction is an act of determining the future value of Avadel Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Avadel Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Avadel Pharmaceuticals and does not consider all of the tangible or intangible factors available from Avadel Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Avadel Pharmaceuticals Plc, which may create opportunities for some arbitrage if properly timed.
Please continue to Avadel Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Avadel Price Prediction 

It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Avadel Pharmaceuticals based on different types of headlines from major news networks to social media. The Avadel stock price prediction module provides an analysis of price elasticity to changes in media outlook on Avadel Pharmaceuticals over a specific investment horizon. Using Avadel Pharmaceuticals hype-based prediction, you can estimate the value of Avadel Pharmaceuticals Plc from the perspective of Avadel Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Avadel Pharmaceuticals using Avadel Pharmaceuticals' options and short interest. It helps to benchmark the overall future attitude of investors towards Avadel using crowd psychology based on the activity and movement of Avadel Pharmaceuticals' stock price.
Avadel Pharmaceuticals EBITDA Margin is relatively stable at the moment as compared to the past year. The company's current value of EBITDA Margin is estimated at 0.46. Earnings per Basic Share is expected to hike to 0.14 this year, although the value of Price to Sales Ratio will most likely fall to 13.63.

Avadel Pharmaceuticals Implied Volatility

Avadel Pharmaceuticals' implied volatility exposes the market's sentiment of Avadel Pharmaceuticals Plc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Avadel Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Avadel Pharmaceuticals stock will not fluctuate a lot when Avadel Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Avadel Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Avadel Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Avadel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Avadel Pharmaceuticals after-hype prediction price

  $ 8.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Avadel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Avadel Pharmaceuticals in the context of predictive analytics.
LowReal ValueHigh
LowNext ValueHigh
9 Analysts
LowTarget PriceHigh
Estimates (7)
LowProjected EPSHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Avadel Pharmaceuticals. Your research has to be compared to or analyzed against Avadel Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Avadel Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Avadel Pharmaceuticals.

Avadel Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Avadel Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Avadel Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Avadel Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Avadel Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Avadel Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Avadel Pharmaceuticals' historical news coverage. Avadel Pharmaceuticals' after-hype downside and upside margins for the prediction period are 4.22 and 12.04, respectively. We have considered Avadel Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
3rd of December 2021
After-hype Price
Avadel Pharmaceuticals is somewhat reliable asset. Analysis and calculation of next after-hype price of Avadel Pharmaceuticals is based on 3 months time horizon.

Avadel Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Avadel Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avadel Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Avadel Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.08  3.91  0.01   0.00  8 Events / Month1 Events / MonthIn about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility 

Avadel Pharmaceuticals Hype Timeline

Avadel Pharmaceuticals is presently traded for 8.14. The entity has historical hype elasticity of -0.01 and average elasticity to hype of competition of 0.0. Avadel is forecasted to decline in value after the next headline with price expected to drop to 8.13. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.12% whereas the daily expected return is presently at 0.08%. The volatility of related hype on Avadel Pharmaceuticals is about 58650.0% with expected price after next announcement by competition of 8.14. About 56.0% of the company shares are held by institutions such as insurance companies. The book value of Avadel Pharmaceuticals was presently reported as 2.33. The company recorded a loss per share of 0.1. Avadel Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecastedpress releasewill be in about 8 days.
Please continue to Avadel Pharmaceuticals Basic Forecasting Models to cross-verify your projections.

Avadel Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Avadel Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Avadel Pharmaceuticals' future price movements. Getting to know how Avadel Pharmaceuticals rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Avadel Pharmaceuticals may potentially react to the hype associated with one of its peers.

Avadel Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Avadel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Avadel using various technical indicators. When you analyze Avadel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Avadel Pharmaceuticals Predictive Indicators

The successful prediction of Avadel Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Avadel Pharmaceuticals Plc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Avadel Pharmaceuticals based on analysis of Avadel Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Avadel Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Avadel Pharmaceuticals's related companies.

Story Coverage note for Avadel Pharmaceuticals

The number of cover stories for Avadel Pharmaceuticals depends on current market conditions and Avadel Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Avadel Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Avadel Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Avadel Pharmaceuticals Short Properties

Avadel Pharmaceuticals' future price predictability will typically decrease when Avadel Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Avadel Pharmaceuticals Plc often depends not only on the future outlook of the potential Avadel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avadel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out6.05%
Float Shares44.78M
Shares Short Prior Month3.73M
Average Daily Volume Last 10 Day454.42k
Average Daily Volume In Three Month719.33k
Date Short Interest15th of October 2021
Please continue to Avadel Pharmaceuticals Basic Forecasting Models to cross-verify your projections. Note that the Avadel Pharmaceuticals information on this page should be used as a complementary analysis to other Avadel Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Avadel Stock analysis

When running Avadel Pharmaceuticals price analysis, check to measure Avadel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avadel Pharmaceuticals is operating at the current time. Most of Avadel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Avadel Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Avadel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Avadel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Directory
Find actively traded corporate debentures issued by US companies
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Avadel Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Avadel Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.